Riverfield key facts
as of Oct 2026- Developer of advanced medical robotics designed to enhance the precision and safety of minimally invasive surgeries.
- Riverfield is valued at approximately $112.6M as of Oct 2026 (last reported valuation).
- It has raised $43.1M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Mitsubishi UFJ Capital, SBI Investment, J-Startup, Beyond Next Ventures, Japan Post Capital — 22 tracked in total.
- Status: Privately Held (backing).
Riverfield's last reported valuation, Sep 2021. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch Riverfield: the Monday email on marks, rounds and moves
Riverfield funding rounds
No funding rounds for Riverfield are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Riverfield
22+Riverfield valuation
Riverfield's last reported valuation was $113 million in Sep 2021. No priced round, secondary trade or fund mark has surfaced since.
Riverfield investors
22 investors are on record for Riverfield, including Mitsubishi UFJ Capital, SBI Investment, J-Startup and Beyond Next Ventures. By type, the record holds 4 venture capital firms and 1 private equity firm.
About Riverfield
Developer of advanced medical robotics designed to enhance the precision and safety of minimally invasive surgeries. The company offers pneumatic control technology, ISO-certified safety design, and surgeon-centered product development, enabling healthcare professionals to perform delicate surgical procedures with greater accuracy, efficiency, and patient comfort.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2014
- Employees
- 62
- Website
- riverfieldinc.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.